Provider Resources

CardioRisk

CardioRisk Laboratories is a national service company offering Carotid Intima Media Thickness (CIMT) screening to primary care physicians, cardiologists, and other health care professionals to help them identify and reduce cardiac, and cerebrovascular events in their patients.

Cleveland HeartLab

Cleveland HeartLab is a Clinical Reference Laboratory specializing in next-generation cardiovascular disease (CVD) prevention, diagnosis and management, including testing for inflammatory and other biomarkers of risk for CV events.

Fujifilm SonoSite

Fujifilm SonoSite, Inc. is a world leader in bedside and point-of-care ultrasound, and an industry leader in ultra-high frequency micro-ultrasound technology. Its hand-carried and portable systems have such cardiology applications as Carotid Intima Media Thickness (CIMT) screening and evaluation of cardiac structures to identify issues, such as pericardial effusion.

MyGenetx

MyGenetx is a healthcare laboratory offering advanced genetics in cardiology, including testing for familial hypercholesterolemia, haptoglobin genotyping, and pharmacogenetics (a genetic panel to determine how patients metabolize many prescription medications), as well as additional genetic testing to help identify risks related to CVD.

OralDNA Labs

OralDNA Labs helps medical and dental professionals in all healthcare settings and their patients use salivary diagnostics to obtain precise evidence about periodontal disease and oral HPV, allowing more accurate diagnosis and, in the case of periodontal disease, more effective, personalized treatment, that may help reduce inflammation and associated CV risk.

Vasolabs, Inc

Vasolabs, Inc is the largest mobile ultrasound service provider. Specializing in cardiovascular tests such as Abdominal Aortic Aneurism testing, Echocardiograms (with interpretation), Ankle Brachia Index and Carotid Intima Media Thickness (CIMT) screening to primary care physicians, specialists, and other health care professionals to help identify and reduce CV events in their patients.